Snowball logo
logo
EQL

EQL Pharma AB

EQL ST
SEK 25.15+SEK 1.45  (6.12%)
Estimate
P/E
59.9
EPS
0.42
Beta
0.392
Growth
Revenue, YoY
30.3%
Net income, YoY
-136.92%
FCF, YoY
99.81%
Forecast
P/E (FWD)
7.4
EPS (FWD)
3.38
About the company
Ticker
EQL
ISIN
SE0005497732
Country
Sweden
Sector (GICS)
Other
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.

Frequently asked questions

What sector does EQL Pharma AB (EQL) operate in?

EQL Pharma AB belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is EQL Pharma AB (EQL) current stock price?

As of the latest data, EQL Pharma AB stock price is SEK 25.15, with a previous close of SEK 23.70. EQL Pharma AB gained SEK 1.45 in the last trading session, representing a 6.12% increase.

What is EQL Pharma AB (EQL) current market capitalization?

EQL Pharma AB market cap is approximately 742.67 million.

What is EQL Pharma AB (EQL) Earnings Per Share (EPS)?

The trailing EPS is SEK 0.42, and the forward EPS is SEK 3.38.

What is EQL Pharma AB (EQL) Price-to-Earnings (P/E) ratio?

EQL Pharma AB current P/E ratio is 59.88, with a forward P/E of 7.44.

Does EQL Pharma AB (EQL) pay dividends?

No. EQL Pharma AB does not pay a dividend.

How did EQL Pharma AB (EQL) perform in its most recent earnings report?

In the last report (March 31, 2026), EQL Pharma AB posted an EPS surprise of -218.18% and a revenue surprise of -71.99%.

What is EQL Pharma AB (EQL) beta (volatility) score?

EQL Pharma AB has a beta of 0.392, indicating lower volatility than the overall market.